Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gilbert

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Biometrics|November 27, 2008
Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trialsZhiguo Li, Peter Gilbert, Bin Nan
The Annals of Applied Statistics|April 3, 2023
SENSITIVITY ANALYSIS FOR EVALUATING PRINCIPAL SURROGATE ENDPOINTS RELAXING THE EQUAL EARLY CLINICAL RISK ASSUMPTIONYing Huang, Yingying Zhuang, Peter Gilbert
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Biocide abuse and antimicrobial resistance: being clear about the issuesPeter Gilbert, Andrew J McBain, Sally F Bloomfield
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is VaccinatedDean Follmann, Michael Fay, Craig Magaret, et al.
The British Journal of Nutrition|May 24, 2013
Cross-sectional study of factors that influence the 25-hydroxyvitamin D status in pregnant women and in cord blood in GermanyCatrin Wuertz, Peter Gilbert, Wolfgang Baier, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Biofilms, homoserine lactones and biocide susceptibilityHarriet G MacLehose, Peter Gilbert, David G Allison
Journal of Basic Microbiology|September 28, 2005
Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosaAmal G Al-Bakri, Peter Gilbert, David G Allison
The Journal of Antimicrobial Chemotherapy|May 1, 2004
Selection for high-level resistance by chronic triclosan exposure is not universalAndrew J McBain, Ruth G Ledder, Prem Sreenivasan, et al.
The Annals of Applied Statistics|January 27, 2009
A Bayesian Framework for Estimating Vaccine Efficacy per Infectious ContactYang Yang, Peter Gilbert, Ira M Longini, et al.
The International Journal of Biostatistics|July 8, 2022
A varying-coefficient partially linear transformation model for length-biased data with an application to HIV vaccine studiesAlan T K Wan, Wei Zhao, Peter Gilbert, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Biometrics|November 27, 2008
Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trialsZhiguo Li, Peter Gilbert, Bin Nan
The Annals of Applied Statistics|April 3, 2023
SENSITIVITY ANALYSIS FOR EVALUATING PRINCIPAL SURROGATE ENDPOINTS RELAXING THE EQUAL EARLY CLINICAL RISK ASSUMPTIONYing Huang, Yingying Zhuang, Peter Gilbert
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Biocide abuse and antimicrobial resistance: being clear about the issuesPeter Gilbert, Andrew J McBain, Sally F Bloomfield
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is VaccinatedDean Follmann, Michael Fay, Craig Magaret, et al.
The British Journal of Nutrition|May 24, 2013
Cross-sectional study of factors that influence the 25-hydroxyvitamin D status in pregnant women and in cord blood in GermanyCatrin Wuertz, Peter Gilbert, Wolfgang Baier, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Biofilms, homoserine lactones and biocide susceptibilityHarriet G MacLehose, Peter Gilbert, David G Allison
Journal of Basic Microbiology|September 28, 2005
Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosaAmal G Al-Bakri, Peter Gilbert, David G Allison
The Journal of Antimicrobial Chemotherapy|May 1, 2004
Selection for high-level resistance by chronic triclosan exposure is not universalAndrew J McBain, Ruth G Ledder, Prem Sreenivasan, et al.
The Annals of Applied Statistics|January 27, 2009
A Bayesian Framework for Estimating Vaccine Efficacy per Infectious ContactYang Yang, Peter Gilbert, Ira M Longini, et al.
The International Journal of Biostatistics|July 8, 2022
A varying-coefficient partially linear transformation model for length-biased data with an application to HIV vaccine studiesAlan T K Wan, Wei Zhao, Peter Gilbert, et al.
Pageof 10